Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73K Sell
20
-63
-76% -$5.38K ﹤0.01% 549
2026
Q1
$7.44K Sell
83
-39
-32% -$3.75K ﹤0.01% 353
2025
Q4
$11.3K Buy
+122
New +$13.3K ﹤0.01% 231
2025
Q1
Sell
-216
Closed -$23.5K 479
2024
Q4
$23.5K Buy
216
+11
+5% +$1.23K ﹤0.01% 234
2024
Q3
$21.9K Buy
+205
New +$20.7K ﹤0.01% 138
2024
Q2
Sell
-38
Closed -$3.52K 269
2024
Q1
$3.52K Buy
+38
New +$3.06K ﹤0.01% 169
2023
Q3
Sell
-26
Closed -$1.88K 505
2023
Q2
$1.88K Buy
+26
New +$1.64K ﹤0.01% 447
2022
Q3
Sell
-77
Closed -$4K 615
2022
Q2
$4K Buy
77
+5
+7% +$248 ﹤0.01% 305
2022
Q1
$4K Buy
+72
New +$4.03K ﹤0.01% 227

Other funds holding ITRI

Elequin Capital's ITRI Position: Q2 2026 in Review

Elequin Capital reduced its Itron (ITRI) stake by 76% in Q2 2026, selling an estimated $5.38K and leaving 20 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Elequin Capital first reported a position in ITRI in Q1 2022 and has held it in 9 quarters since. The position peaked at $23.5K in Q4 2024. 414 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Elequin Capital held 20 shares of Itron worth $1.73K as of Q2 2026.
  • Elequin Capital sold 63 Itron shares in Q2 2026, an estimated $5.38K.
  • Itron made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #549 holding.
  • Elequin Capital first reported a position in Itron in Q1 2022 and has held it in 9 quarters since.
  • Elequin Capital's Itron position peaked at $23.5K in Q4 2024.
  • 414 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.